{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:23:29Z","timestamp":1779247409131,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ajog.2014.09.014","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T01:17:21Z","timestamp":1410830241000},"page":"318.e1-318.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women"],"prefix":"10.1016","volume":"212","author":[{"given":"Andrew M.","family":"Kaunitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Daniel R.","family":"Mishell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Foegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2014.09.014_bib1","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMe1204769","article-title":"Hormonal contraceptives and arterial thrombosis\u2014not risk-free but safe enough","volume":"366","author":"Petitti","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.09.014_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"},{"issue":"Pt 2","key":"10.1016\/j.ajog.2014.09.014_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9378(99)70718-0","article-title":"Causes and consequences of oral contraceptive noncompliance","volume":"180","author":"Rosenberg","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.09.014_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hec.609","article-title":"The impact of non-compliance on the cost effectiveness of pharmaceuticals: a review of the literature","volume":"10","author":"Hughes","year":"2001","journal-title":"Health Econ"},{"key":"10.1016\/j.ajog.2014.09.014_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2014.09.014_bib6","series-title":"Ortho Evra [prescribing information]","year":"2001"},{"key":"10.1016\/j.ajog.2014.09.014_bib7","unstructured":"Petition to ban ethinyl estradiol\/norelgestromin (Ortho-Evra). Public Citizen [Web site]. Updated May 8, 2008. Available at: http:\/\/www.citizen.org\/notmypatch. Accessed May 1,\u00a02013."},{"key":"10.1016\/j.ajog.2014.09.014_bib8","series-title":"Ortho Evra [prescribing information]","year":"2011"},{"key":"10.1016\/j.ajog.2014.09.014_bib9","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-2010","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2014.09.014_bib10","unstructured":"US Food and Drug Administration, Office of Surveillance and Epidemiology. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints. FDA, 2011. Available at: www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM277384.pdf. Accessed May 1,\u00a02013."},{"key":"10.1016\/j.ajog.2014.09.014_bib11","unstructured":"US Food and Drug Administration Drug Safety Communication: updated information about the risk of blood clots in women taking birth control pills containing drospirenone. 2012.\u00a0Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm299305. Accessed June 9,\u00a02014."},{"key":"10.1016\/j.ajog.2014.09.014_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","article-title":"Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives","volume":"89","author":"Dinger","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2014.09.014_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2014.09.014_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.contraception.2009.08.001","article-title":"Contraceptive considerations in obese women: release date September 1, 2009, SFP Guideline 20091","volume":"80","author":"Higginbotham","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2014.09.014_bib15","first-page":"231","article-title":"Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinyl estradiol and levonorgestrel","volume":"6","author":"Stanczyk","year":"2011","journal-title":"Horm Mol Biol Clin Invest"},{"key":"10.1016\/j.ajog.2014.09.014_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2012.10.009","article-title":"Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity, and exercise","volume":"87","author":"Archer","year":"2013","journal-title":"Contraception"},{"issue":"2 Pt 1","key":"10.1016\/j.ajog.2014.09.014_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/AOG.0000000000000095","article-title":"Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial","volume":"123","author":"Kaunitz","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.09.014_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2014.09.014_bib19","unstructured":"Agile Therapeutics. An open-label, randomized, phase 3 study of the contraceptive efficacy and safety of agile transdermal contraceptive delivery system (TCDS) in comparison to an oral contraceptive containing 150 mcg levonorgestrel and 30 mcg ethinyl estradiol. Available at: ClinicalTrials.gov [Web site]. Bethesda, MD. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01236768. NLM identifier: NCT01236768. Accessed May 1,\u00a02013."},{"key":"10.1016\/j.ajog.2014.09.014_bib20","first-page":"1","article-title":"Prevalence of obesity in the United States, 2009-2010","volume":"82","author":"Ogden","year":"2012","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajog.2014.09.014_bib21","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2014.09.014_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2014.09.014_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.contraception.2011.10.006","article-title":"Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial","volume":"85","author":"Archer","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2014.09.014_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2014.01.013","article-title":"Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel\/ethinyl estradiol combined oral contraceptive","volume":"89","author":"Portman","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2014.09.014_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.09.019","article-title":"Predictors of noncompliance in an oral contraceptive clinical trial","volume":"85","author":"Westhoff","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2014.09.014_bib26","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1161\/01.CIR.0000031705.57473.1C","article-title":"Upper-extremity deep vein thrombosis","volume":"106","author":"Joffe","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2014.09.014_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2014.09.014_bib28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/AOG.0b013e31825194ca","article-title":"Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective","volume":"119","author":"Raymond","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.09.014_bib29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2009.12.016","article-title":"Ortho Evra and venous thromboembolism: an update","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814009442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814009442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:01:08Z","timestamp":1757588468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937814009442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0002937814009442"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2014.09.014","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2014.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}